Reassessment of subscription price for Lumito TO1 subscription warrants
According to the terms and conditions for series Lumito TO1 subscription warrants, the subscription price shall be reassessed under certain conditions, such as when a preferential rights issue takes place during the warrant life of Lumito TO1. Since Lumito has recently conducted a preferential rights issue, the subscription price for LUMITO TO1 has been reassessed […]
Annual General Meeting of Lumito AB (publ) 2019
The annual general meeting of Lumito AB (publ), held in Lund on 4 June 2019, passed the following resolutions. Resolution on approval of the income statement and balance sheet, etc. The annual general meeting resolved to approve the income statement and balance sheet for the financial year 2018. The Board of Directors and the Managing […]
Lumito AB is provided approximately MSEK 38.7 in cash through an over-subscribed rights issue and a decided over-allotment
Lumito AB (publ) announces today that the Company's new share issue amounting to approximately MSEK 35.7 has been subscribed to a total of 155 percent. The commitments from the guarantee consortium do therefore not have to be utilized. In addition, an over-allotment issue of MSEK 3.0 has been decided. An extraordinary general meeting of Lumito […]
Lumito’s public new share issue oversubscribed
Lumito AB’s recently completed public new share issue resulted in the subscription of units (share plus warrant) for a total value of approximately MSEK 20.4 before transaction costs. This corresponds to a subscription rate of 102 percent of the offering. – We are very happy with the outcome, says Lumito’s CEO, Stefan Nilsson. – Considering […]
Lumito holds presentation on the Nordic Symposium on Digital Pathology
On 16 May, Lumito will demonstrate its technology under the theme "Open Innovation" on the Nordic Symposium on Digital Pathology in Linköping, with 200 expected participants from more than 10 countries. – This is an excellent opportunity to give a comprehensive presentation of our technology, and to meet pathologists and other representatives in the field […]
The Board of Directors’s adjusted proposal for authorization to resolve on new issues
The Board of Directors of Lumito AB (publ) has decided to adjust its proposal under the item 10 on the agenda for the annual general meeting on 4 June 2019. The adjustment means that the following passage is removed: ” Such new issues may in total be comprised of at most the equivalent of 11,200,000 […]
Lumito publishes prospectus for preferential rights issue
This press release may not be announced, published or distributed, either directly or indirectly, in or to the United States, Australia, Japan, New Zealand, South Africa, The Republic of Korea, Canada or any other country in which such action is wholly or partly subject to legal restrictions. In order to facilitate and accelerate the development […]
Communiqué from the extraordinary general meeting of Lumito AB (publ)
The extraordinary general meeting of Lumito AB (publ) on 25 April 2019 passed the following resolutions: Item 7 – Decision regarding the approval of the Board of Directors's proposal to issue new shares and warrants (units) Lumito’s Board of Directors has, conditional on the approval of the General Meeting, resolved to conduct a new issue […]
The Board of Lumito AB has decided to move the Annual General Meeting to 4 June
The Board of Lumito has decided to move the annual general meeting from 22 May to 4 June. The reason for the postponement is that the annual general meeting otherwise would have taken place in the middle of the subscription period for the new rights issue, as suggested by the Board. A notice convening the […]
Convocation of Extraordinary General Meeting of shareholders of Lumito AB (publ)
Shareholders of Lumito AB (publ), 556832-0062, are hereby convened to an Extraordinary General Meeting on Thursday, 25 April 2019, at 10:00 a.m. at Magistratsvägen 10, 226 43 Lund, Sweden. A. Right to participate at the Extraordinary General Meeting Shareholders who wish to participate at the extraordinary general meeting must be registered in the share […]
